Opinion

Video

TAR-200 Clinical Development Program in NMIBC

Experts briefly mention other ongoing phase 3 studies investigating TAR-200 for the treatment of non–muscle-invasive bladder cancer (NMIBC).

Video Player is loading.
Current Time 0:00
Duration 5:12
Loaded: 0%
Stream Type LIVE
Remaining Time 5:12
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Video content above is prompted by the following:

    • Can you briefly mention other ongoing phase 3 studies with TAR-200?

    Newsletter

    Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

    Related Content
    © 2025 MJH Life Sciences

    All rights reserved.